Activation of the androgen receptor (AR) despite androgen ablation and anti-androgen therapy seems to play a pivotal role in hormone-refractory progression of prostate cancer. The above postulation is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback